PURPOSE: Our laboratory has developed and implanted a novel bioengineered internal anal sphincter (IAS) to treat anal incontinence. Fibroblast growth factor-2 (FGF-2) has been used in mice; however, the optimal growth factor for successful IAS implantation is unclear. This study compares several growth factors in order to optimize IAS viability and functionality. METHODS: Bioengineered IAS rings were implanted subcutaneously into the dorsum of wildtype C57Bl/6 mice, with an osmotic pump dispensing FGF-2, vascular endothelial growth factor (VEGF), or platelet-derived growth factor (PDGF) (n = 4 per group). Control mice received IAS implants but no growth factor. The IAS was harvested approximately 25 days post-implantation. Tissue was subjected to physiologic testing, then histologically analyzed. Muscle phenotype was confirmed by immunofluorescence. RESULTS: All implants supplemented with growth factors maintained smooth muscle phenotype. Histological scores, blood vessel density and muscle fiber thickness were all markedly better with growth factors. Neovascularization was comparable between the three growth factors. Basal tonic force of the constructs was highest with VEGF or PDGF. CONCLUSION: All growth factors demonstrated excellent performance. As our ultimate goal is clinical implantation, our strong results with PDGF, a drug approved for use in the United States and the European Union, pave the way for translating bioengineered IAS implantation to the clinical realm.
PURPOSE: Our laboratory has developed and implanted a novel bioengineered internal anal sphincter (IAS) to treat anal incontinence. Fibroblast growth factor-2 (FGF-2) has been used in mice; however, the optimal growth factor for successful IAS implantation is unclear. This study compares several growth factors in order to optimize IAS viability and functionality. METHODS: Bioengineered IAS rings were implanted subcutaneously into the dorsum of wildtype C57Bl/6 mice, with an osmotic pump dispensing FGF-2, vascular endothelial growth factor (VEGF), or platelet-derived growth factor (PDGF) (n = 4 per group). Control mice received IAS implants but no growth factor. The IAS was harvested approximately 25 days post-implantation. Tissue was subjected to physiologic testing, then histologically analyzed. Muscle phenotype was confirmed by immunofluorescence. RESULTS: All implants supplemented with growth factors maintained smooth muscle phenotype. Histological scores, blood vessel density and muscle fiber thickness were all markedly better with growth factors. Neovascularization was comparable between the three growth factors. Basal tonic force of the constructs was highest with VEGF or PDGF. CONCLUSION: All growth factors demonstrated excellent performance. As our ultimate goal is clinical implantation, our strong results with PDGF, a drug approved for use in the United States and the European Union, pave the way for translating bioengineered IAS implantation to the clinical realm.
Authors: S Perry; C Shaw; C McGrother; R J Matthews; R P Assassa; H Dallosso; K Williams; K R Brittain; U Azam; M Clarke; C Jagger; C Mayne; C M Castleden Journal: Gut Date: 2002-04 Impact factor: 23.059
Authors: Shreya Raghavan; Eiichi A Miyasaka; Mohamed Hashish; Sita Somara; Robert R Gilmont; Daniel H Teitelbaum; Khalil N Bitar Journal: Am J Physiol Gastrointest Liver Physiol Date: 2010-06-17 Impact factor: 4.052
Authors: Jason W Cooke; David P Sarment; Louis A Whitesman; Sarah E Miller; Qiming Jin; Samuel E Lynch; William V Giannobile Journal: Tissue Eng Date: 2006-06
Authors: Mikko Larsen; Wouter F Willems; Michael Pelzer; Patricia F Friedrich; Michael J Yaszemski; Allen T Bishop Journal: J Orthop Res Date: 2010-08 Impact factor: 3.494
Authors: Roger D P Stanzel; Sandra Lourenssen; Dileep G Nair; Michael G Blennerhassett Journal: Am J Physiol Cell Physiol Date: 2010-07-14 Impact factor: 4.249
Authors: Mohamed Hashish; Shreya Raghavan; Sita Somara; Robert R Gilmont; Eiichi Miyasaka; Khalil N Bitar; Daniel H Teitelbaum Journal: J Pediatr Surg Date: 2010-01 Impact factor: 2.545
Authors: Giuseppe Orlando; Kathryn J Wood; Paolo De Coppi; Pedro M Baptista; Kyle W Binder; Khalil N Bitar; Christopher Breuer; Luke Burnett; George Christ; Alan Farney; Marina Figliuzzi; James H Holmes; Kenneth Koch; Paolo Macchiarini; Sayed-Hadi Mirmalek Sani; Emmanuel Opara; Andrea Remuzzi; Jeffrey Rogers; Justin M Saul; Dror Seliktar; Keren Shapira-Schweitzer; Tom Smith; Daniel Solomon; Mark Van Dyke; James J Yoo; Yuanyuan Zhang; Anthony Atala; Robert J Stratta; Shay Soker Journal: Ann Surg Date: 2012-05 Impact factor: 12.969
Authors: Shreya Raghavan; Eiichi A Miyasaka; Robert R Gilmont; Sita Somara; Daniel H Teitelbaum; Khalil N Bitar Journal: Surgery Date: 2013-12-27 Impact factor: 3.982
Authors: Christopher M Walthers; Alireza K Nazemi; Shilpy L Patel; Benjamin M Wu; James C Y Dunn Journal: Biomaterials Date: 2014-03-30 Impact factor: 12.479